Christopher Wiltshire
Directeur Général chez Hematherix LLC
Profil
Christopher Wiltshire is the founder of Hematherix LLC (founded in 2015),.
Ipt Bioconsulting LLC (founded in 2008), and Hemastasyx Ltd.
(founded in 2015) where he holds the title of Chief Executive Officer.
He previously worked as the Head of Business Transactions & Investments at The Pfizer Incubator LLC from 1998 to 2008.
From 2018 to 2022, he worked as the Executive Director & Chief Business Officer at Ovoca Bio Plc.
He also worked as the Head of Business Development & Licensing at La Jolla Pharmaceutical Co. Mr. Wiltshire graduated from the University of Cambridge and holds an MBA from the University of Virginia Darden School of Business.
Postes actifs de Christopher Wiltshire
Sociétés | Poste | Début |
---|---|---|
Hematherix LLC | Directeur Général | 01/01/2015 |
Hemastasyx Ltd. | Directeur Général | 01/01/2015 |
Anciens postes connus de Christopher Wiltshire
Sociétés | Poste | Fin |
---|---|---|
OVOCA BIO PLC | Directeur/Membre du Conseil | 31/01/2022 |
Ipt Bioconsulting LLC | Fondateur | 01/01/2015 |
The Pfizer Incubator LLC | Corporate Officer/Principal | 01/01/2008 |
LA JOLLA PHARMACEUTICAL COMPANY | Corporate Officer/Principal | - |
Formation de Christopher Wiltshire
University of Cambridge | Graduate Degree |
University of Virginia Darden School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
OVOCA BIO PLC | Health Technology |
Entreprise privées | 5 |
---|---|
Hematherix LLC | |
Ipt Bioconsulting LLC | |
The Pfizer Incubator LLC | |
La Jolla Pharmaceutical Co.
La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
Hemastasyx Ltd. |